{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T02:38:22.29763+00:00","published_at":"2026-10-16T13:54:58.592666+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1g864c4740ry8","event_type":"CFO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:aaron-rosenberg","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:e275cb23595829c0f10aa3e7854cef6ecbe9bdbd31c013d0feb4aaafa0cfc93c"],"summary":"Aaron Rosenberg executive of BeOne Medicines Ltd., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kjr9mgwe9ate","event_type":"GC_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:cassandra-s-lee","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:e893aa632e5892274f2291d7201d572e20a6a9466492a80f57a29c324166ad45"],"summary":"Chan Lee executive of BeOne Medicines Ltd., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ga6vcc182weay","event_type":"CEO_CHANGED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:john-v-oyler-2","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:b6e15390d2d6119974cf3fe8fa45264339f72c61711b44875935336c885c5ad8"],"summary":"John V. Oyler executive of BeOne Medicines Ltd., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ph1hup10x3r4z","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:lai-wang","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:20"],"evidence_ids":["alpha:projection-evidence:document:9985057967159017cd590a0070d6701c81cddabbee55017db558fe13f42f0a24"],"summary":"Lai Wang executive of BeOne Medicines Ltd., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y10rui1xycfy8","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-28","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:xiaobin-wu","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:21"],"evidence_ids":["alpha:projection-evidence:document:987b55552a7aa3419874bf9873ed017d30349473c71a5e72108b75b30cc00544"],"summary":"Xiaobin Wu executive of BeOne Medicines Ltd., effective 2026-04-28.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6rm7y440osqk","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:olivier-brandicourt","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Olivier Brandicourt seat on BeOne Medicines Ltd., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ghmwfzym3497","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:shalini-sharp","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Shalini Sharp seat on BeOne Medicines Ltd., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:krl3kx1xr0g7r","event_type":"COMMITTEE_CREATED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:committee:beone-medicines-ltd:audit-chair-nominating-and-governance","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Audit · Chair; Nominating and Governance committee of BeOne Medicines Ltd., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wswanp12fqvep","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:shalini-sharp","alpha:committee:beone-medicines-ltd:audit-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Shalini Sharp member of Audit · Chair; Nominating and Governance, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ag59prls9kbb","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:alessandro-riva","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Alessandro Riva seat on BeOne Medicines Ltd., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16foiirhvv04","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:margaret-dugan","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Margaret Dugan seat on BeOne Medicines Ltd., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ufdbe4jnoi8g","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:committee:beone-medicines-ltd:compensation-chair","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Compensation · Chair committee of BeOne Medicines Ltd., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1trdltb1jvie9t","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:margaret-dugan","alpha:committee:beone-medicines-ltd:compensation-chair"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Margaret Dugan member of Compensation · Chair, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1nltvfmynnmjk","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:alessandro-riva","alpha:committee:beone-medicines-ltd:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:committee_record:31"],"evidence_ids":["alpha:projection-evidence:1537aedfadb357e0f4eb9b3e8bc3edbb25cb61c6cfdc1a405e33162b7bd6c836"],"summary":"Alessandro Riva member of Nominating and Governance, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:118hxky189f594","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:anthony-c-hooper","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Anthony C. Hooper seat on BeOne Medicines Ltd., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:82dbw112jcgwf","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:corazon-d-sanders","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Corazon D. Sanders seat on BeOne Medicines Ltd., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ty1du61aj7gaw","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:committee:beone-medicines-ltd:audit-nominating-and-governance-chair","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Audit; Nominating and Governance · Chair committee of BeOne Medicines Ltd., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1yn4qvi6c0lzq","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:anthony-c-hooper","alpha:committee:beone-medicines-ltd:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Anthony C. Hooper member of Audit; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vychkj172hcyd","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:xiaodong-wang","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Xiaodong Wang seat on BeOne Medicines Ltd., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1vtfztbsnyjb5","event_type":"DIRECTOR_APPOINTED","effective_at":"2015-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:michael-goller","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Michael Goller seat on BeOne Medicines Ltd., effective 2015-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ikbmzaacln5y","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:qingqing-yi","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Qingqing Yi seat on BeOne Medicines Ltd., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14b1ijp1nis0nt","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:ranjeev-krishana","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"Ranjeev Krishana seat on BeOne Medicines Ltd., effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fddqpl180derl","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2014-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:qingqing-yi","alpha:committee:beone-medicines-ltd:compensation"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:committee_record:27"],"evidence_ids":["alpha:projection-evidence:1537aedfadb357e0f4eb9b3e8bc3edbb25cb61c6cfdc1a405e33162b7bd6c836"],"summary":"Qingqing Yi member of Compensation, effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1mhvilbnxq8p","event_type":"DIRECTOR_APPOINTED","effective_at":"2010-01-01","detected_at":"2026-10-16T13:54:58.592666+00:00","subject_ids":["alpha:person:john-v-oyler-2","alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80"],"caused_claim_ids":["alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213"],"summary":"John V. Oyler seat on BeOne Medicines Ltd., effective 2010-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:6","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alessandro-riva","object_label":"Alessandro Riva","object_source_name_forms":[],"value":"Alessandro Riva: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alessandro-riva","name":"Alessandro Riva"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:7","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anthony-c-hooper","object_label":"Anthony C. Hooper","object_source_name_forms":[],"value":"Anthony C. Hooper: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anthony-c-hooper","name":"Anthony C. Hooper"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:8","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:corazon-d-sanders","object_label":"Corazon D. Sanders","object_source_name_forms":[],"value":"Corazon D. Sanders: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:corazon-d-sanders","name":"Corazon D. Sanders"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:9","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-v-oyler-2","object_label":"John V. Oyler","object_source_name_forms":[],"value":"John V. Oyler: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-v-oyler-2","name":"John V. Oyler"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2010-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2010-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2010-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:10","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-dugan","object_label":"Margaret Dugan","object_source_name_forms":[],"value":"Margaret Dugan: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:margaret-dugan","name":"Margaret Dugan"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:11","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-goller","object_label":"Michael Goller","object_source_name_forms":[],"value":"Michael Goller: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-goller","name":"Michael Goller"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:12","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:olivier-brandicourt","object_label":"Olivier Brandicourt","object_source_name_forms":[],"value":"Olivier Brandicourt: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:olivier-brandicourt","name":"Olivier Brandicourt"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:13","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:qingqing-yi","object_label":"Qingqing Yi","object_source_name_forms":[],"value":"Qingqing Yi: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:qingqing-yi","name":"Qingqing Yi"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:14","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ranjeev-krishana","object_label":"Ranjeev Krishana","object_source_name_forms":[],"value":"Ranjeev Krishana: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ranjeev-krishana","name":"Ranjeev Krishana"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:15","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:shalini-sharp","object_label":"Shalini Sharp","object_source_name_forms":[],"value":"Shalini Sharp: Director, Audit · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:shalini-sharp","name":"Shalini Sharp"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:16","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:xiaodong-wang","object_label":"Xiaodong Wang","object_source_name_forms":[],"value":"Xiaodong Wang: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:xiaodong-wang","name":"Xiaodong Wang"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-07","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:17","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:aaron-rosenberg","object_label":"Aaron Rosenberg","object_source_name_forms":[],"value":"Aaron Rosenberg: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:aaron-rosenberg","name":"Aaron Rosenberg"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:e275cb23595829c0f10aa3e7854cef6ecbe9bdbd31c013d0feb4aaafa0cfc93c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:18","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:cassandra-s-lee","object_label":"Chan Lee","object_source_name_forms":[],"value":"Chan Lee: Senior Vice President, General Counsel and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:cassandra-s-lee","name":"Chan Lee"},"title":"Senior Vice President, General Counsel and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:e893aa632e5892274f2291d7201d572e20a6a9466492a80f57a29c324166ad45","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:19","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:john-v-oyler-2","object_label":"John V. Oyler","object_source_name_forms":[],"value":"John V. Oyler: Co-Founder, Chairman and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:john-v-oyler-2","name":"John V. Oyler"},"title":"Co-Founder, Chairman and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:b6e15390d2d6119974cf3fe8fa45264339f72c61711b44875935336c885c5ad8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:20","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lai-wang","object_label":"Lai Wang","object_source_name_forms":[],"value":"Lai Wang: President, Global Head of Research and Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lai-wang","name":"Lai Wang"},"title":"President, Global Head of Research and Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:9985057967159017cd590a0070d6701c81cddabbee55017db558fe13f42f0a24","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:leadership_role:21","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:xiaobin-wu","object_label":"Xiaobin Wu","object_source_name_forms":[],"value":"Xiaobin Wu: President and Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:xiaobin-wu","name":"Xiaobin Wu"},"title":"President and Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-28","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-28","valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:document:987b55552a7aa3419874bf9873ed017d30349473c71a5e72108b75b30cc00544","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-28T00:00:00+00:00","effective_from":"2026-04-28","effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:committee_record:27","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Margaret Dugan; Members Margaret Dugan (Chair); Qingqing Yi; Ranjeev Krishana","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Margaret Dugan","members":[{"display_name":"Margaret Dugan","person_slug":"margaret-dugan","is_chair":true},{"display_name":"Qingqing Yi","person_slug":"qingqing-yi","is_chair":false},{"display_name":"Ranjeev Krishana","person_slug":"ranjeev-krishana","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:1537aedfadb357e0f4eb9b3e8bc3edbb25cb61c6cfdc1a405e33162b7bd6c836","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80:committee_record:31","subject_id":"alpha:company:8dd3a2de-77d2-437e-81cb-f1f92e2f1e80","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Anthony C. Hooper; Members Anthony C. Hooper (Chair); Alessandro Riva; Michael Goller; Shalini Sharp","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Anthony C. Hooper","members":[{"display_name":"Anthony C. Hooper","person_slug":"anthony-c-hooper","is_chair":true},{"display_name":"Alessandro Riva","person_slug":"alessandro-riva","is_chair":false},{"display_name":"Michael Goller","person_slug":"michael-goller","is_chair":false},{"display_name":"Shalini Sharp","person_slug":"shalini-sharp","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:54:58.592666+00:00","sources":[{"id":"alpha:projection-evidence:1537aedfadb357e0f4eb9b3e8bc3edbb25cb61c6cfdc1a405e33162b7bd6c836","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:f925321ea678c349ec95d4caeb0fd846a13aa9e6bfdc6a443548c3a94dbed213","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Onconova Therapeutics DEF 14A 2025-04-07","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":"2025-04-07","retrieved_at":"2026-04-24T22:46:01.315+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e275cb23595829c0f10aa3e7854cef6ecbe9bdbd31c013d0feb4aaafa0cfc93c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e893aa632e5892274f2291d7201d572e20a6a9466492a80f57a29c324166ad45","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b6e15390d2d6119974cf3fe8fa45264339f72c61711b44875935336c885c5ad8","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9985057967159017cd590a0070d6701c81cddabbee55017db558fe13f42f0a24","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:987b55552a7aa3419874bf9873ed017d30349473c71a5e72108b75b30cc00544","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BEIGF DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465926049655/tm261479-4_def14a.htm","source_date":"2026-04-28T00:00:00+00:00","retrieved_at":"2026-07-28T17:06:28.9483+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:1537aedfadb357e0f4eb9b3e8bc3edbb25cb61c6cfdc1a405e33162b7bd6c836","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465925032346/tm252440-6_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.836,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.877,"cross_source_agreement":0.75,"temporal_completeness":0.593},"diagnostics":{"published_claims":37,"factual_claims":37,"claims_with_linked_evidence":37,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":27,"temporal_claims_with_valid_from":16,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:54:58.592666+00:00","observed_at":"2026-10-16T13:54:58.592666+00:00","reviewed_at":"2026-10-16T13:54:58.592666+00:00","verified_at":"2026-10-16T13:54:58.592666+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":37,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/beone-medicines-ltd/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/beone-medicines-ltd?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}